Patents by Inventor Christopher John Corrigan

Christopher John Corrigan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9861606
    Abstract: A calcium/cation-sensing receptor (CaSR) antagonist to treat an inflammatory lung disorder is described. Methods of treatment including the antagonist, combination therapeutics including the antagonist and at least one other agent, and nebulizers or inhalers including the antagonist are also described.
    Type: Grant
    Filed: September 25, 2013
    Date of Patent: January 9, 2018
    Assignees: KING'S COLLEGE LONDON, UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED
    Inventors: Daniela Riccardi, Paul Jeffrey Kemp, Christopher John Corrigan, Jeremy Patrick Thomas Ward
  • Publication number: 20160271095
    Abstract: The invention concerns a calcium/cation-sensing receptor (CaSR) antagonist to treat an inflammatory lung disorder; a method of treatment involving said antagonist; a combination therapeutic comprising said antagonist and at least one other agent; and a nebuliser or inhaler containing same.
    Type: Application
    Filed: September 25, 2013
    Publication date: September 22, 2016
    Inventors: Daniela Riccardi, Paul Jeffrey Kemp, Christopher John Corrigan, Jeremy Patrick Thomas Ward
  • Publication number: 20150216833
    Abstract: A calcium/cation-sensing receptor (CaSR) antagonist to treat an inflammatory lung disorder is described. Methods of treatment including the antagonist, combination therapeutics including the antagonist and at least one other agent, and nebulisers or inhalers including the antagonist are also described.
    Type: Application
    Filed: September 25, 2013
    Publication date: August 6, 2015
    Applicants: UNIVERSITY COLLEGE CARDIFF CONSULTANTS LIMITED, KING'S COLLEGE LONDON
    Inventors: Daniela Riccardi, Paul Jeffrey Kemp, Christopher John Corrigan, Jeremy Patrick Thomas Ward